Genetic Epidemiology Branch, National Cancer Institute , USA
Wen-Qing Li got his Ph.D. in Epidemiology and Biostatistics from Peking University, China, in July, 2010, where he studied the gene-environmental interaction in the evolution of precancerous gastric lesions, as well as the genetic factors which determine the effect of chemo-intervention trials. He then came to Brigham and Women’s Hospital, Harvard Medical School as a research fellow, where he worked on risk factors and co-morbidities of skin cancer and skin diseases basing on the Nurses’ Health Study (NHS), NHS II, and Health Professionals’ Follow-up Study. He joined the Genetic Epidemiology Branch (GEB), Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health as a postdoctoral fellow in 2012, and is primarily working on the gene-environmental interaction in upper gastrointestinal cancer, melanoma, and lung cancer. He also keeps collaboration with Harvard collaborators investigating the genetic and environmental factors in melanoma, and with collaborators in China on the follow-up of Helicobacter pylori treatment in preventing progression of precancerous gastric lesions and development of gastric cancer.
Epidemiology studies to investigate the effects of environmental factors on the development of non-communicable diseases, particularly gastrointestinal cancers, skin cancer, and skin diseases. Gene-environmental interaction for development of cancers, particularly gastrointestinal cancers.Co-morbidities of non-communicable diseases. Specific interest in large intervention trial to prevent the progression of precancerous lesions and development of cancers.